Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis

Abstract

Monocytes/macrophages play a central role in chronic inflammatory disorders, including rheumatoid arthritis (RA). Activation of these cells results in the production of various mediators responsible for inflammation and RA pathogenesis. On the other hand, the depletion of macrophages using specific antibodies or chemical agents can prevent their synovial tissue infiltration and subsequently attenuates inflammation. Their plasticity is a major feature that helps the switch from a pro-inflammatory phenotype (M1) to an anti-inflammatory state (M2). Therefore, understanding the precise strategy targeting pro-inflammatory monocytes/macrophages should be a powerful way of inhibiting chronic inflammation and bone erosion. In this review, we demonstrate potential consequences of different epigenetic regulations on inflammatory cytokines production by monocytes. In addition, we present unique profiles of monocytes/macrophages contributing to identification of new biomarkers of disease activity or predicting treatment response in RA. We also outline novel approaches of tuning monocytes/macrophages by biologic drugs, small molecules or by other therapeutic modalities to reduce arthritis. Finally, the importance of cellular heterogeneity of monocytes/macrophages is highlighted by single-cell technologies, which leads to the design of cell-specific therapeutic protocols for personalized medicine in RA in the future.

Alterations between Autophagy and Apoptosis in Alveolar Bone Mesenchymal Stem Cells under Orthodontic Force and Their Effects on Osteogenesis

“…Therefore, it is difficult to control orthodontic force accurately in the clinic. Personalized therapy, based on an individual's molecular and cellular biological background, has been introduced to the management of various diseases, including cancers 37,38) , bone diseases 39) and immune disorders 40) . Personalized therapy might be a promising strategy for the precise control of tooth movement.…”

Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies

“…In addition, these cell types also play important roles in tissue repair and angiogenesis. Rheumatic diseases such as RA, SLE and SpA are characterized by an aberrant activation of immune cells, both from innate and adaptive system [21][22][23][24]. Given the relevance of monocytes and macrophages in the pathogenesis of SpA, this review aims to analyse the role and function of these cell types in these diseases, as well as the impact of different clinical treatments on monocyte and macrophage activity.…”

Efficient Treatment of Rheumatoid Arthritis by Degradable LPCE Nano-Conjugate-Delivered p65 siRNA

“…Regarding RA, research has already recognized that inflammation is closely related to its occurrence and progression. This inflammatory process is regulated by various cytokines released by immune cells and further leads to elevation of the inflammatory response by activating endothelial cells and recruiting more immune cells, leading to accumulation [10,11]. During RA, the infiltration of a large number of macrophages in synovial tissue initiates a variety of other immune cells, and this activated inflammatory cascade further results in cartilage and bone destruction [12][13][14].…”